~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
Parts of the World Seeing New COVID-19 Variant
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity
Rates of Drug Use-Associated Infective Endocarditis Declined From 2020 to 2022
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis